3 completed, 2 terminated, 1 recruiting, 1 withdrawn. 7 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Terminated 2, Recruiting 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Oxandrolone: new trials by email Literature Review of Oxandrolone trials Research Report on Oxandrolone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Subdermal Implant-bioabsorbable Oxandrolone Pellet For Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgical Reconstruction Oxandrolone, Placebo - Anterior Cruciate Ligament (ACL) Reconstruction | Phase 2 | Recruiting | Science Valley Research Institute | 96 | 2025-11-28 | 2026-08-25 |
| Use of Oxandrolone to Promote Growth in Infants With HLHS Oxandrolone - Hypoplastic Left Heart, Congenital Heart Disease | Phase 1 / Phase 2 | Terminated | Carelon Research | 34 | 2019-12-20 | 2024-05-23 |
| RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone Iron sucrose, Oxandrolone, IV iron placebo - Functional Iron Deficiency, Trauma | Phase 2 | Withdrawn | Denver Health and Hospital Authority | 2015-01-01 | 2019-04-03 | |
| Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation Stable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI - Burns | Phase 2 / Phase 3 | Terminated | The University of Texas Medical Branch, Galveston | 1126 | 2004-01-01 | 2019-11-29 |
| Assessment of Mechanisms of Improved Wound Healing Stable Isotope Infusion study, Insulin High Dose, oxandrolone - Burns | Phase 2 / Phase 3 | Completed | The University of Texas Medical Branch, Galveston | 644 | 2000-07-01 | 2023-07-03 |
| Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome growth hormone, oxandrolone - Turner's Syndrome | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 80 | 1999-10-01 | 2008-09-10 |
| The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome Humatrope, Oxandrolone - Dwarfism, Turner's Syndrome | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 80 | 1992-12-11 | 2017-07-02 |
Burns (2) · Turner Syndrome (2) · Anemia (1) · Dwarfism (1) · Genetic Diseases, Inborn (1) · Heart Defects, Congenital (1) · Hypoplastic Left Heart Syndrome (1) · Motor Activity (1) · Rare Diseases (1) · Sarcopenia (1) · Wounds and Injuries (1)
The University of Texas Medical Branch, Galveston (2) · Carelon Research (1) · Denver Health and Hospital Authority (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Science Valley Research Institute (1)
United States (6) · Brazil (1) · Canada (1)
David N Herndon, MD (1) · David N. Herndon, MD (1) · Eduardo Ramacciotti, MD, PhD (1) · Fredric M Pieracci, MD, MPH (1) · Judith L Ross (1) · Phillip T Burch, MD (1) · Richard V Williams, MD (1) · Roberto Tauchmann, MD (1)
PMID 22606232, PMID 18791359, PMID 19240154, PMID 19734776, PMID 20395554, PMID 20701787, PMID 20739853, PMID 20881067, PMID 21789167, PMID 22463890, PMID 22895351, PMID 23150682, PMID 23303450, PMID 23511841, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25807408, PMID 27171844, PMID 27433905, PMID 28240622, PMID 36656551
P50GM060338 (2), R01GM056687 (1)